Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Single-dose parenteral iron is safe and effective for children with inflammatory bowel disease and iron-deficiency anemia.

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Methotrexate plus prednisolone had the fewest serious side effects.

Nocturnal calcium infusions improved a boy's severe rickets without causing hair loss.

Oral steroids may effectively treat recurrent intussusception in children with ILH, possibly avoiding surgery.

Bifidobacterium animalis subsp. lactis J12 helps reduce atopic dermatitis symptoms.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

Rituximab can cause skin issues, but baricitinib may help improve them.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Lenalidomide helps hair follicle stem cells turn into melanocytes, which may improve repigmentation in vitiligo.

Dupilumab may help treat hair loss and skin color loss in some patients with atopic dermatitis.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Combining cetirizine and topical steroids can effectively manage severe lichen planus pilaris.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

A man with multiple autoimmune diseases developed liver injury from azathioprine, but his liver improved after stopping the drug.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Enteral nutrition's role in maintaining Crohn's disease remission is unclear and needs more research.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Upadacitinib may effectively treat resistant lichen planopilaris.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Leflunomide with prednisone is effective and well-tolerated for lupus nephritis when cyclophosphamide can't be used.